Expert Review of Anticancer Therapy

SJR Rank #6,431H-index: 91SJR: 0.840Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • OncologyQ2
  • Pharmacology (medical)Q2

Areas: Medicine

Most published research topics

Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer TreatmentsRenal cell carcinoma treatmentCancer Genomics and DiagnosticsProstate Cancer Treatment and ResearchLung Cancer Research StudiesHER2/EGFR in Cancer ResearchColorectal Cancer Treatments and StudiesLymphoma Diagnosis and Treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs095190285380

Documents per Year

2022202504080120160

Detailed Information

ISSN

1473-7140, 1744-8328

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.84

References per Document

72.31

Coverage

2001-2026

Scope

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.

Metrics from SCImago Journal Rank 2025. View on SCImago